These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Mackinnon S, Barnett L, Bourhis JH, Black P, Heller G, O'Reilly RJ. Blood; 1992 Dec 15; 80(12):3235-41. PubMed ID: 1467526 [Abstract] [Full Text] [Related]
6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M. Biol Blood Marrow Transplant; 2001 Dec 15; 7(12):646-55. PubMed ID: 11787527 [Abstract] [Full Text] [Related]
7. Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation. Schaap N, Schattenberg A, Mensink E, Preijers F, Hillegers M, Knops R, Pennings A, Boezeman J, Geurts van Kessel A, de Pauw B, de Witte T. Leukemia; 2002 Jan 15; 16(1):13-21. PubMed ID: 11840258 [Abstract] [Full Text] [Related]
10. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Jefri A, Al-Ahmari A, Ayas M, El-Solh H. Biol Blood Marrow Transplant; 2010 Jun 15; 16(6):818-23. PubMed ID: 20079864 [Abstract] [Full Text] [Related]
12. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703 [Abstract] [Full Text] [Related]
17. A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors. Kalwak K, Mosoń I, Cwian J, Gorczyńska E, Toporski J, Turkiewicz D, Latos-Grazyńska E, Chybicka A. Transplant Proc; 2003 Jun 15; 35(4):1551-5. PubMed ID: 12826218 [Abstract] [Full Text] [Related]
18. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients. Arnold DE, MacMath D, Seif AE, Heimall JR, Wang Y, Monos D, Grupp SA, Bunin NJ. Transplant Cell Ther; 2021 Feb 15; 27(2):169.e1-169.e9. PubMed ID: 33830028 [Abstract] [Full Text] [Related]
19. T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Hentschke P, Omazic B, Mattsson J, Näsman-Björk I, Lundkvist I, Gigliotti D, Barkholt L, Ringdén O, Remberger M. Scand J Immunol; 2005 Mar 15; 61(3):285-94. PubMed ID: 15787747 [Abstract] [Full Text] [Related]